Cargando…

Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

BACKGROUND: We sought to describe global patterns in achievement of risk factor control for primary prevention in patients with T2D and explore the association of country's GNI/capita with risk factor control. METHODS: The DISCOVER study is a prospective, observational study of patients with T2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malik, Ali O., Chen, Hungta, Tang, Fengming, Chan, Paul S., Cooper, Andrew, Gomes, Marίlia B., Hejjaji, Vittal, Ji, Linong, Khunti, Kamlesh, Kosiborod, Mikhail, Nicolucci, Antonio, Peri-Okonny, Poghni A., Shestakova, Marina V., Vora, Jiten, Watada, Hirotaka, Arnold, Suzanne V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647648/ https://www.ncbi.nlm.nih.gov/pubmed/35926587 http://dx.doi.org/10.1016/j.ihj.2022.07.008

Ejemplares similares

Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study
por: Arnold, Suzanne V., et al.
Publicado: (2022)

Glycaemic control in patients with type 2 diabetes initiating second‐line therapy: Results from the global DISCOVER study programme
por: Khunti, Kamlesh, et al.
Publicado: (2019)

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
por: Arnold, Suzanne V., et al.
Publicado: (2022)

Type 2 diabetes and heart failure: insights from the global DISCOVER study
por: Arnold, Suzanne V., et al.
Publicado: (2021)

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)
por: Kosiborod, Mikhail, et al.
Publicado: (2018)

Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
por: Bongaerts, Brenda, et al.
Publicado: (2021)

Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme
por: Nicolucci, Antonio, et al.
Publicado: (2019)

Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second‐line glucose‐lowering therapy: The global DISCOVER study
por: Charbonnel, Bernard H., et al.
Publicado: (2022)

Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study
por: Gomes, Marília B., et al.
Publicado: (2022)

Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study
por: Patel, Krishna K., et al.
Publicado: (2020)

Mobile App to Improve House Officers’ Adherence to Advanced Cardiac Life Support Guidelines: Quality Improvement Study
por: Hejjaji, Vittal, et al.
Publicado: (2020)

Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study
por: Pintat, Stéphane, et al.
Publicado: (2019)

Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany
por: Khunti, Kamlesh, et al.
Publicado: (2017)

Long COVID — metabolic risk factors and novel therapeutic management
por: Khunti, Kamlesh, et al.
Publicado: (2021)

Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes
por: Arnold, Suzanne V., et al.
Publicado: (2020)

Comanagement of Risk Factors in Patients With Coronary Artery Disease: Insights From the APPEAR Study
por: Hejjaji, Vittal, et al.
Publicado: (2020)

Association of Diabetes Mellitus With Health Status Outcomes in Patients With Peripheral Artery Disease: Insights From the PORTRAIT Registry
por: Patel, Krishna K., et al.
Publicado: (2020)

Differential effects of eplerenone versus amlodipine on muscle metaboreflex function in hypertensive humans
por: Peri‐Okonny, Poghni A., et al.
Publicado: (2021)

Physical Activity After Percutaneous Coronary Intervention for Chronic Total Occlusion and Its Association With Health Status
por: Peri‐Okonny, Poghni A., et al.
Publicado: (2019)

Are we running out of fish? Fish, health and sustainability
por: Khetan, Aditya, et al.
Publicado: (2023)

Association of Statin Use and Mortality After Transcatheter Aortic Valve Replacement
por: Peri‐Okonny, Poghni A., et al.
Publicado: (2019)

Long covid: risk factors, outcomes, and future directions for research
por: O'Mahoney, Lauren, et al.
Publicado: (2022)

Association of Perceived Stress Levels With Long-term Mortality in Patients With Peripheral Artery Disease
por: Malik, Ali O., et al.
Publicado: (2020)

Association of Disease‐Specific Health Status With Long‐Term Survival in Peripheral Artery Disease
por: Tran, Andy T., et al.
Publicado: (2022)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
por: Khunti, Kamlesh, et al.
Publicado: (2017)

Methods and rationale of the DISCOVER CKD global observational study
por: Pecoits-Filho, Roberto, et al.
Publicado: (2021)

Economy of Russian Regions in the Pandemic: Are Resilience Factors At Work?
por: Kuznetsova, O. V.
Publicado: (2021)

The economy of you: discover your inner entrepreneur and recession-proof your life
por: Palmer, Kimberly
Publicado: (2014)

Emerging role of insulin with incretin therapies for management of type 2 diabetes
por: Ahluwalia, Rupa, et al.
Publicado: (2011)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

Usefulness of Blood Pressure Variability Indices Derived From 24‐Hour Ambulatory Blood Pressure Monitoring in Detecting Autonomic Failure
por: Lodhi, Hamza A., et al.
Publicado: (2019)

Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol
por: Katakami, Naoto, et al.
Publicado: (2017)

Healthy lifestyle choices and microvascular complications: New insights into diabetes management
por: Chudasama, Yogini V., et al.
Publicado: (2023)

Discovering in vitro spermatogenesis stimulating factors
por: Chaudhary, J, et al.
Publicado: (2015)

Eligibility of patients with type 2 diabetes for sodium‐glucose co‐transporter‐2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry
por: Wittbrodt, Eric, et al.
Publicado: (2019)

Recently Discovered Human Coronaviruses
por: Wevers, Brigitte A., et al.
Publicado: (2009)

Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry(®)
por: Arnold, Suzanne V., et al.
Publicado: (2017)

The Effectiveness of Screening for Diabetes and Cardiovascular Disease Risk Factors in a Community Pharmacy Setting
por: Willis, Andrew, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r7irn5r269thn4vdmd0js92a41